Literature DB >> 24999118

Dengue hemorrhagic fever: comparison of patients with primary and secondary infections.

Muhammad Khurram1, Wajeeha Qayyum2, Syed Jawad Ul Hassan1, Shamaila Mumtaz1, Hamama Tul Bushra1, Muhammad Umar1.   

Abstract

BACKGROUND: Dengue hemorrhagic fever (DHF) is considered to be associated with secondary dengue infection. This study was conducted to note frequency of primary and secondary dengue infection in DHF patients. Additionally these patients were compared in terms of age, gender, laboratory parameter, diseases severity and outcome.
MATERIALS AND METHODS: In this cross sectional observational study DHF patients fulfilling DHF criteria of Dengue Expert Advisory Group (DEAG) were included and divided into groups based on dengue specific IgG positivity and ratio of IgM to IgG. Group I, patients with secondary dengue infection were IgG positive or their ratio of IgM to IgG was <1.2. Group II, primary dengue infection patients were IgG negative or their ratio of IgM to IgG was >1.2. The two Groups were compared for statistically significant association in terms of age, gender, laboratory parameter (at admission hematocrit [HCT], platelet, white blood cell [WBC] counts, alanine aminotransferase [ALT] value), severity (DHF or dengue shock syndrome), and outcome (recovered or expired).
RESULTS: Two hundred thirty-four DHF patients were included. 66.2% was male and 33.8% female. Mean patient age was 28.8 ± 12.4 years. Based on dengue markers results, 61.5% patients were categorized to Group I, and 38.5% to Group II. Statistically significant association between the two Groups was noted in terms of at admission platelet count, and ALT value, P value <0.05.
CONCLUSION: Primary dengue infection is frequently associated with DHF. Patients with DHF caused by secondary dengue infection have lower at admission platelet counts and higher ALT value.
Copyright © 2014 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alanine aminotransferase; Dengue; Dengue hemorrhagic fever; Platelet count; Primary and secondary dengue infection

Mesh:

Substances:

Year:  2014        PMID: 24999118     DOI: 10.1016/j.jiph.2014.05.005

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  9 in total

1.  Differential expression of NADPH oxidase-2 (Nox-2) and nuclear factor-erythroid 2-related factor 2 (Nrf2) transcripts in peripheral blood mononuclear cells isolated from dengue patients.

Authors:  Cleetus Cherupanakkal; Vijayakumar Ramachadrappa; Tamilarasu Kadhiravan; Narayanan Parameswaran; Subhash Chandra Parija; Agieshkumar Balakrishna Pillai; Soundravally Rajendiran
Journal:  Virusdisease       Date:  2017-02-13

2.  A Study on Gene Expression Profile of Endogenous Antioxidant Enzymes: CAT, MnSOD and GPx in Dengue Patients.

Authors:  Cleetus Cherupanakkal; Vijayakumar Ramachadrappa; Tamilarasu Kadhiravan; Narayanan Parameswaran; Subhash Chandra Parija; Agieshkumar Balakrishna Pillai; Soundravally Rajendiran
Journal:  Indian J Clin Biochem       Date:  2017-01-16

3.  The Epidemiology, Virology and Clinical Findings of Dengue Virus Infections in a Cohort of Indonesian Adults in Western Java.

Authors:  Herman Kosasih; Bachti Alisjahbana; Quirijn de Mast; Irani F Rudiman; Susana Widjaja; Ungke Antonjaya; Harli Novriani; Nugroho H Susanto; Hadi Jusuf; Andre van der Ven; Charmagne G Beckett; Patrick J Blair; Timothy H Burgess; Maya Williams; Kevin R Porter
Journal:  PLoS Negl Trop Dis       Date:  2016-02-12

4.  Dengue Hemorrhagic Fever in a Japanese Traveler with Pre-existing Japanese Encephalitis Virus Antibody.

Authors:  Rumi Sato; Nobuyuki Hamada; Takahito Kashiwagi; Yoshihiro Imamura; Koyu Hara; Munetsugu Nishimura; Tomoko Kamimura; Tomohiko Takasaki; Hiroshi Watanabe; Takeharu Koga
Journal:  Trop Med Health       Date:  2015-02-04

Review 5.  Epidemiological Characteristics and Risk Factors of Dengue Infection in Korean Travelers.

Authors:  Sungmo Je; Wonjun Bae; Jiyeon Kim; Seung Hyeok Seok; Eung Soo Hwang
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

Review 6.  Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz; Nereida Jiménez de Oya
Journal:  Front Cell Infect Microbiol       Date:  2018-02-15       Impact factor: 5.293

7.  Cross-serotype interactions and disease outcome prediction of dengue infections in Vietnam.

Authors:  R Aguas; I Dorigatti; L Coudeville; C Luxemburger; N M Ferguson
Journal:  Sci Rep       Date:  2019-06-28       Impact factor: 4.379

8.  Genome-Wide Analysis to Identify HLA Factors Potentially Associated With Severe Dengue.

Authors:  Sudheer Gupta; Ankita Agarwal; Amod Kumar; Debasis Biswas
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

9.  Time elapsed between Zika and dengue virus infections affects antibody and T cell responses.

Authors:  Erick X Pérez-Guzmán; Petraleigh Pantoja; Crisanta Serrano-Collazo; Mariah A Hassert; Alexandra Ortiz-Rosa; Idia V Rodríguez; Luis Giavedoni; Vida Hodara; Laura Parodi; Lorna Cruz; Teresa Arana; Laura J White; Melween I Martínez; Daniela Weiskopf; James D Brien; Aravinda de Silva; Amelia K Pinto; Carlos A Sariol
Journal:  Nat Commun       Date:  2019-09-20       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.